Updated on 1 September 2026
Contactless Predictive Health Alert System (CPHAS)
Chief Clinical Information Officer at CPHAS Ltd
China (Hong Kong)
About
The project aims to develop an automated contactless clinical screening and risk‑prediction system for use in critical care, with applications in construction, transport and aviation. Developing Ultrawide band radar (UWB) but using JintzMed ’heart‑rate variability monitor and additional physiological, demographic, and lifestyle data. Clinical experts and data scientists will develop unique AI algorithms based on validated national clinical guidelines and tools e.g. Acutely ill adults in hospital: recognising and responding to deterioration
www.nice.org.uk/guidance/cg50 and the National Early Warning Score 2 (NEWS2)
Future applications include:
-
Early detection of cardiac disease (especially myocardial infarction risk)
-
Early detection of vascular dementia risk
-
Integration into primary care, community clinics, and employer health programmes
-
Long‑term population‑level risk stratification and preventive health planning
-
CPHAS alert health screening for construction workers
-
CPHAS CAB -UWB Radar in the cab for construction workers to prevent critical incidents before they happen
Contactless, predictive ultra-wide band (UWB) radar-based patient monitoring and alert system (CPHAS ) established in Hong Kong in 2026 by JintzMed (Hong Kong) and Nine Health (United Kingdom). JintzMed has developed innovative diagnostic devices for cardiovascular risk, autonomous nervous system assessment and mental stress. An NMPA license has been granted for the heart rate variability (HRV) analyzer using a novel algorithmic model to enhance short-range remote monitoring of multiple vital signs. Nine Health was the data lead in a major European project (VPH-share) involved in silico medicine and supercomputational modelling since 2012; in 2015-2017 with Lantone(Hangzhou) an NMPA approved diagnostic AI system was developed. Successfully worked with UK National Health Service (NHS) in 2020/21 to develop a predictive AI wound-healing app.
UWB monitors respiration, heart rate, heart-rate variability, body motion and potentially blood pressure and oxygen saturation,) 24/7 without connecting the patient to wires, clips or pads. Using an AI risk prediction score combines any changes in vital signs with other data to predict critical incidents like stroke, sepsis and heart attack. The system accuracy improves via machine learning.
The system is primarily designed for use in healthcare. Effective and reliable contactless, predictive, continuous patient monitoring system is described by a leading Hong Kong private hospital as “the holy grail”. There is no such system currently available. CPHAS will alleviate shortages of care staff by enhancing efficiency: one clinician could monitor more patients and care can be prioritized. Predictive AI provides alerts in advance. Evidence shows that human observations are too late and do not achieve good outcomes. It is also applicable to care home and domestic settings and we are exploring this application with Hong Kong University.
We have attracted great interest from, automotive, construction and other industries. Funded by the NHS AI Awards competition https://fundingawards.nihr.ac.uk/award/AI_AWARD01723 we were able to predict those at risk of developing hard to heal wounds, the disease pathway and other key outcomes enabling prevention. Applying this methodology in Hong Kong and China together with ultra Wide Radar (UWB) we expect to create a prototype system over the next 9 months
Project Location
- China (Hong Kong)
Project Website
https://www.CPHAS.HK
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Idea / Concept Stage
Government approval on
15/05/2026
Contract awarded on
15/05/2026
Target completion by
31/03/2027
Main Project Sector
- Technology
Technology
- Health Technology
- Medical Technology
- Smart City Technology
- IoT
Transport and Logistics
- Urban Rail And Transport Facilities
Urban Development
- Health Facilities
- Smart City Development
Total Project Value
- 500,001 to 1,000,000 USD
Investment Capital Required
- 500,000 USD or Below
Interested Format of Cooperation
- Direct Equity Investment
- Open for Negotiation
Preferred Financing Model
- Equity
- Open for negotiation
Type(s) of Last Financing Round of the project (if Applicable)
- Bootstrapping
Total amount raised (USD)
33850
Main Service(s) Required
- Financial Services
Financial Services
- Institutional Investment
- Private Equity & Venture Capital
Attached files
Organisation
China (Hong Kong)
Similar opportunities
Project
Contactless Predictive Health Alert System (CPHAS)
- No
- Yes
- IoT
- Equity
- Technology
- Bootstrapping
- Private Project
- Health Technology
- Health Facilities
- Medical Technology
- Financial Services
- Idea / Concept Stage
- 500,000 USD or Below
- Open for negotiation
- Smart City Technology
- Open for Negotiation
- Smart City Development
- 500,001 to 1,000,000 USD
- Direct Equity Investment
- Institutional Investment
- Private Equity & Venture Capital
- Urban Rail And Transport Facilities
Robin Weir
CEO at CPHAS Ltd
China (Hong Kong)
Project
Electrophysiological data validity engineering and trustworthy medical AI Infrastructure
- Yes
- Yes
- IoT
- Technology
- Joint Venture
- Private Project
- Health Technology
- Equity (private)
- Medical Technology
- Financial Services
- Open for negotiation
- Open for Negotiation
- Direct Equity Investment
- 1,000,001 to 2,500,000 USD
- 10,000,001 to 25,000,000 USD
- Investment / Financing Discussion
- M&A / Strategic Acquisition Opportunity
Helen Lam
CEO at Hong Kong Jintz Medical Technology Co., Limited
China (Hong Kong)
Project
HelixBridge Two-Way Care Navigation AI Agent – Cross-Border Healthcare Collaboration
- Yes
- Yes
- Equity
- Technology
- IP Related
- IT Security
- Bootstrapping
- Legal Advisory
- Private Project
- Health Facilities
- Financial Services
- Business Valuation
- Financial Advisory
- Smart City Technology
- Open for Negotiation
- Professional Services
- Partner Identification
- Minority Shareholdings
- Smart City Development
- 500,001 to 1,000,000 USD
- 500,001 to 1,000,000 USD
- Institutional Investment
- Market Entry Strategic Analysis
Jade WANG
Founder/CEO at HelixBridge Limited
China (Hong Kong)